Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. (Q42681901)
scientific article published on August 1998
Language:
(P31) (Q13442814)
(P50) (Q56689362)
(P304) 370-390
(P407) (Q1860)
(P433) 4
(P478) 19
(P577) Saturday, August 1, 1998
(P921) (Q410291)
(P1433) (Q5164971)
(P1476) "Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial" (language: en)
(P2093) H R Black
W J Elliott
J D Neaton
G Grandits
P Grambsch
R H Grimm
L Hansson
Y Lacoucière
J Muller
P Sleight
M A Weber
W B White
G Williams
J Wittes
T D Fakouhi
(P2860) (Q29391703)
(Q35187653)
(Q50934595)
(Q34727882)
(Q34734009)
(Q72398848)
(Q41125477)
(Q70890586)
(Q38508613)
(Q34303127)
(Q51036865)
(Q51009944)
(Q71396282)
(Q45154192)
(Q68572775)
(Q71003913)
(Q68891365)
(Q69921762)
(Q41113132)
(Q40517041)
(Q58038076)
(Q69717894)
(Q72786077)
(Q57746161)
(Q41186974)
(Q40907938)
(Q72505292)
(Q72909009)
(Q29619842)
(Q34347537)
(Q46103117)
(Q71969309)
(Q42279386)
(Q40590980)
(Q68323341)
(Q28328155)
(Q67588661)
(Q34289578)
(Q41356030)
(Q47342714)
(Q52570205)
(Q28248823)
other details
description scientific article published on August 1998

External Links